オンコロジー用栄養の世界市場レポート 2025年

オンコロジー用栄養の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.9％で30億6,000万米ドルに成長します。予測期間の成長は、がん罹患率の増加、栄養食品需要の増加、世界の臨床試験の増加、可処分所得の上昇に起因すると考えられます。予測期間の主な動向には、個別化栄養、免疫栄養、ゲノム栄養、統合医療、バリュー・ベース・ケアなどがあります。

がん罹患率の増加は、オンコロジー用栄養市場の成長予測に大きく寄与する要因です。がん罹患率は、特定の集団における一定期間の新規がん症例数を指し、増加傾向にあります。がん治療を受けている人々は、特定の食事ニーズを満たす栄養を必要としており、オンコロジー用栄養製品に対する需要を牽引しています。例えば、米国がん協会は2023年1月に、がん罹患者数が2023年には1,958,310人に増加し、2021年の1,898,160人から3.16%の伸びを示したと報告しています。その結果、がん罹患率の上昇がオンコロジー用栄養市場拡大の原動力になると予測されます。

オンコロジー用栄養市場の成長は、がん研究への投資の増加によっても促進されると予測されます。がん調査への投資は、がんの理解、予防、診断、治療を目的とした科学的試みを支援するための財源を割り当てることを含みます。研究資金が増加することで、栄養とがんの複雑な関係に対する理解が深まり、がん患者特有の食事要件に合わせた特化型製品の開発につながります。例えば、2022年3月、オーストラリアの政府機関である保健・高齢者介護省は、がんサービスおよび転帰を強化するために8億9,350万米ドルを割り当てた。このようながん調査への投資の増加は、オンコロジー用栄養市場の成長を促進すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界のオンコロジー用栄養 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、制約）
• 最終用途産業の分析
• 世界のオンコロジー用栄養市場：成長率分析
• 世界のオンコロジー用栄養市場の実績：規模と成長, 2019-2024
• 世界のオンコロジー用栄養市場の予測：規模と成長, 2024-2029, 2034F
• 世界のオンコロジー用栄養総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のオンコロジー用栄養市場：がんタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血液がん
• 乳がん
• 胃がんおよび消化器がん
• 肝臓がん
• 膵臓がん
• その他のがんタイプ
• 世界のオンコロジー用栄養市場：栄養別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 経腸栄養
• 経腸栄養
• 世界のオンコロジー用栄養市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 在宅ケア
• 専門クリニック
• その他のエンドユーザー
• 世界のオンコロジー用栄養市場：血液がんのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 白血病
• リンパ腫
• 多発性骨髄腫
• 世界のオンコロジー用栄養市場：乳がんのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 早期乳がん
• 進行乳がん
• 世界のオンコロジー用栄養市場：胃がんおよび消化器がんのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 胃がん
• 大腸がん
• 食道がん
• 世界のオンコロジー用栄養市場：肝臓がんのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 肝細胞がん
• 胆管がん
• 世界のオンコロジー用栄養市場：膵臓がんのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 外分泌膵臓がん
• 内分泌膵臓腫瘍
• 世界のオンコロジー用栄養市場：その他のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 肺がん
• 前立腺がん
• 卵巣がん
• 頭頸部がん

第7章 地域別・国別分析

• 世界のオンコロジー用栄養市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のオンコロジー用栄養市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• オンコロジー用栄養市場：競合情勢
• オンコロジー用栄養市場：企業プロファイル
  • B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
  • Danone India Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Nestle S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Hormel Foods Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Meiji Holdings Co. Ltd.
• Pfizer Inc.
• Baxter International Inc.
• Mead Johnson Nutrition Company LLC
• Fresenius Kabi AG
• Mead Johnson & Company LLC
• Global Health Products Inc.
• Nutricia
• Cambrooke Therapeutics Inc.
• Kate Farms Inc.
• Real Food Blends LLC
• Abbott Nutrition
• Fresenius Kabi USA LLC
• Medtrition Inc.
• Nutra Balance Products

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• オンコロジー用栄養市場2029：新たな機会を提供する国
• オンコロジー用栄養市場2029：新たな機会を提供するセグメント
• オンコロジー用栄養市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Oncology nutrition involves the implementation of a healthy and balanced diet specifically tailored for cancer patients. Consuming the right types of food before, during, and after treatment is crucial for helping patients feel better and maintain strength. The goal of oncology nutrition is to enhance clinical outcomes in specific cancer types.

The primary categories of cancer addressed in oncology nutrition include blood cancer, breast cancer, stomach and gastrointestinal cancers, liver cancer, pancreatic cancer, and others. Stomach and gastrointestinal cancers encompass malignancies occurring in any part of the stomach. Various nutritional approaches, such as enteral nutrition and parenteral nutrition, are employed across different settings, including hospitals, homecare, specialty clinics, and other end users.

The oncology nutrition market research report is one of a series of new reports from The Business Research Company that provides oncology nutrition market statistics, including oncology nutrition industry global market size, regional shares, competitors with an oncology nutrition market share, detailed oncology nutrition market segments, market trends and opportunities, and any further data you may need to thrive in the oncology nutrition industry. This oncology nutrition market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

The oncology nutrition market size has grown rapidly in recent years. It will grow from $1.9 billion in 2024 to $2.1 billion in 2025 at a compound annual growth rate (CAGR) of 10.5%. The growth in the historic period can be attributed to aging population, improved healthcare infrastructure, research and development investments, patient-centric care, rise in healthcare spending.

The oncology nutrition market size is expected to see strong growth in the next few years. It will grow to $3.06 billion in 2029 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to increasing cancer incidence, rise in demand for nutritional food, increase in clinical trials globally, rising disposable income. Major trends in the forecast period include personalized nutrition, immuno-nutrition, genomic nutrition, integrative medicine, value-based care.

The increasing prevalence of cancer is a significant factor contributing to the anticipated growth of the oncology nutrition market. Cancer incidence, which refers to the number of new cancer cases within a specific population over a defined period, has been on the rise. Individuals undergoing cancer treatment require nutrition that meets their specific dietary needs, driving the demand for oncology nutrition products. For example, the American Cancer Society reported in January 2023 that the number of cancer cases had increased to 1,958,310 in 2023, marking a growth of 3.16% from 1,898,160 in 2021. Consequently, the escalating incidence of cancer is expected to be a driving force for the expansion of the oncology nutrition market.

The growth of the oncology nutrition market is also anticipated to be fueled by increasing investments in cancer research. Investment in cancer research involves allocating financial resources to support scientific endeavors aimed at understanding, preventing, diagnosing, and treating cancer. Heightened research funding facilitates a deeper comprehension of the intricate relationship between nutrition and cancer, leading to the development of specialized oncology nutrition products tailored to the unique dietary requirements of cancer patients. For instance, in March 2022, the Department of Health and Aged Care, a government agency based in Australia, allocated $893.5 million to enhance cancer services and outcomes. This increased investment in cancer research is expected to drive the growth of the oncology nutrition market.

Major companies in the oncology nutrition market are dedicated to developing innovative solutions, such as nutrition specifically tailored for cancer patients, to enhance treatment outcomes, support immune function, manage side effects related to treatment, and improve overall quality of life during and after cancer therapy. Nutrition for cancer patients encompasses specialized dietary plans and nutritional interventions aimed at addressing the unique needs of individuals undergoing cancer treatment. For example, in June 2024, AEACAP, a patient support association based in Spain, introduced a new nutrition series aimed at assisting cancer patients and their caregivers. This initiative includes a collection of videos released every two weeks, presented by a qualified nutritionist. The series seeks to offer vital information on diet and nutrition throughout and after cancer treatment, emphasizing the essential role that proper nutrition plays in improving treatment outcomes and enhancing the quality of life for those affected by cancer.

Major companies in the oncology nutrition market are focusing on the development of personalized nutrition products to gain a competitive edge. Tality, a medical food based on personalized nutrition designed to inhibit the growth of cancer cells within a short timeframe, is one such example. Filtricine Inc., a US-based biotechnology company, introduced Tality in September 2023, utilizing personalized nutrition to target nutrients essential for cancer cells while sparing normal cells. The Tality meal plan, known as the TND diet, can be used alongside standard patient care or as a standalone treatment, with potential benefits observable in as little as four weeks, according to early results.

In January 2024, Danone S.A., a food company based in France, formed a partnership with National Resilience, Inc. This collaboration aims to improve nutritional care for cancer patients by incorporating a specialized nutrition support module into Resilience's digital oncology platform, focusing on addressing cancer-related malnutrition and enhancing patient outcomes and quality of life during treatment. National Resilience, Inc., a manufacturing and technology company located in the U.S., is committed to expanding access to complex medicines.

Major companies operating in the oncology nutrition market include B. Braun Melsungen AG, Danone India, Abbott Laboratories, Nestle S.A., Hormel Foods Corporation, Meiji Holdings Co. Ltd., Pfizer Inc., Baxter International Inc., Mead Johnson Nutrition Company LLC, Fresenius Kabi AG, Mead Johnson & Company LLC, Global Health Products Inc., Nutricia, Cambrooke Therapeutics Inc., Kate Farms Inc., Real Food Blends LLC, Abbott Nutrition, Fresenius Kabi USA LLC, Medtrition Inc., Nutra Balance Products, Nutritional Medicinals LLC, Pinnacle Foods Inc., Primus Pharmaceuticals Inc., Solace Nutrition, The Simply Good Foods Company, Unimed Pharma LLC, Vitaflo USA LLC

North America was the largest region in the oncology nutrition market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology nutrition market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the oncology nutrition market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The oncology nutrition market includes revenues earned by entities by bladder cancer, breast cancer, colorectal cancer, kidney cancer, and lung cancer. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oncology Nutrition Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oncology nutrition market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for oncology nutrition ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The oncology nutrition market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Cancer Type: Blood Cancer; Breast Cancer; Stomach and Gastrointestinal Cancers; Liver Cancer; Pancreatic Cancer; Other Cancer Types
• 2) By Nutrition: Enteral Nutrition; Parenteral Nutrition
• 3) By End-Users: Hospitals; Homecare; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Blood Cancer: Leukemia; Lymphoma; Multiple Myeloma
• 2) By Breast Cancer: Early-Stage Breast Cancer; Advanced Breast Cancer
• 3) By Stomach and Gastrointestinal Cancers: Gastric Cancer; Colorectal Cancer; Esophageal Cancer
• 4) By Liver Cancer: Hepatocellular Carcinoma; Cholangiocarcinoma
• 5) By Pancreatic Cancer: Exocrine Pancreatic Cancer; Endocrine Pancreatic Tumors
• 6) By Other Cancer Types: Lung Cancer; Prostate Cancer; Ovarian Cancer; Head And Neck Cancers
• Companies Mentioned: B. Braun Melsungen AG; Danone India; Abbott Laboratories; Nestle S.A.; Hormel Foods Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Oncology Nutrition Market Characteristics

3. Oncology Nutrition Market Trends And Strategies

4. Oncology Nutrition Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Oncology Nutrition Growth Analysis And Strategic Analysis Framework

• 5.1. Global Oncology Nutrition PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Oncology Nutrition Market Growth Rate Analysis
• 5.4. Global Oncology Nutrition Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Oncology Nutrition Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Oncology Nutrition Total Addressable Market (TAM)

6. Oncology Nutrition Market Segmentation

• 6.1. Global Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Cancer
• Breast Cancer
• Stomach and Gastrointestinal Cancers
• Liver Cancer
• Pancreatic Cancer
• Other Cancer Types
• 6.2. Global Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Enteral Nutrition
• Parenteral Nutrition
• 6.3. Global Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End Users
• 6.4. Global Oncology Nutrition Market, Sub-Segmentation Of Blood Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Leukemia
• Lymphoma
• Multiple Myeloma
• 6.5. Global Oncology Nutrition Market, Sub-Segmentation Of Breast Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Early-Stage Breast Cancer
• Advanced Breast Cancer
• 6.6. Global Oncology Nutrition Market, Sub-Segmentation Of Stomach and Gastrointestinal Cancers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Gastric Cancer
• Colorectal Cancer
• Esophageal Cancer
• 6.7. Global Oncology Nutrition Market, Sub-Segmentation Of Liver Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hepatocellular Carcinoma
• Cholangiocarcinoma
• 6.8. Global Oncology Nutrition Market, Sub-Segmentation Of Pancreatic Cancer, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Exocrine Pancreatic Cancer
• Endocrine Pancreatic Tumors
• 6.9. Global Oncology Nutrition Market, Sub-Segmentation Of Other Cancer Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lung Cancer
• Prostate Cancer
• Ovarian Cancer
• Head And Neck Cancers

7. Oncology Nutrition Market Regional And Country Analysis

• 7.1. Global Oncology Nutrition Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Oncology Nutrition Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Oncology Nutrition Market

• 8.1. Asia-Pacific Oncology Nutrition Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Oncology Nutrition Market

• 9.1. China Oncology Nutrition Market Overview
• 9.2. China Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Oncology Nutrition Market

• 10.1. India Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Oncology Nutrition Market

• 11.1. Japan Oncology Nutrition Market Overview
• 11.2. Japan Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Oncology Nutrition Market

• 12.1. Australia Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Oncology Nutrition Market

• 13.1. Indonesia Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Oncology Nutrition Market

• 14.1. South Korea Oncology Nutrition Market Overview
• 14.2. South Korea Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Oncology Nutrition Market

• 15.1. Western Europe Oncology Nutrition Market Overview
• 15.2. Western Europe Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Oncology Nutrition Market

• 16.1. UK Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Oncology Nutrition Market

• 17.1. Germany Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Oncology Nutrition Market

• 18.1. France Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Oncology Nutrition Market

• 19.1. Italy Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Oncology Nutrition Market

• 20.1. Spain Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Oncology Nutrition Market

• 21.1. Eastern Europe Oncology Nutrition Market Overview
• 21.2. Eastern Europe Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Oncology Nutrition Market

• 22.1. Russia Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Oncology Nutrition Market

• 23.1. North America Oncology Nutrition Market Overview
• 23.2. North America Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Oncology Nutrition Market

• 24.1. USA Oncology Nutrition Market Overview
• 24.2. USA Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Oncology Nutrition Market

• 25.1. Canada Oncology Nutrition Market Overview
• 25.2. Canada Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Oncology Nutrition Market

• 26.1. South America Oncology Nutrition Market Overview
• 26.2. South America Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Oncology Nutrition Market

• 27.1. Brazil Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Oncology Nutrition Market

• 28.1. Middle East Oncology Nutrition Market Overview
• 28.2. Middle East Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Oncology Nutrition Market

• 29.1. Africa Oncology Nutrition Market Overview
• 29.2. Africa Oncology Nutrition Market, Segmentation By Cancer Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Oncology Nutrition Market, Segmentation By Nutrition, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Oncology Nutrition Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Oncology Nutrition Market Competitive Landscape And Company Profiles

• 30.1. Oncology Nutrition Market Competitive Landscape
• 30.2. Oncology Nutrition Market Company Profiles
  • 30.2.1. B. Braun Melsungen AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Danone India Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Nestle S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Hormel Foods Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Oncology Nutrition Market Other Major And Innovative Companies

• 31.1. Meiji Holdings Co. Ltd.
• 31.2. Pfizer Inc.
• 31.3. Baxter International Inc.
• 31.4. Mead Johnson Nutrition Company LLC
• 31.5. Fresenius Kabi AG
• 31.6. Mead Johnson & Company LLC
• 31.7. Global Health Products Inc.
• 31.8. Nutricia
• 31.9. Cambrooke Therapeutics Inc.
• 31.10. Kate Farms Inc.
• 31.11. Real Food Blends LLC
• 31.12. Abbott Nutrition
• 31.13. Fresenius Kabi USA LLC
• 31.14. Medtrition Inc.
• 31.15. Nutra Balance Products

32. Global Oncology Nutrition Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Oncology Nutrition Market

34. Recent Developments In The Oncology Nutrition Market

35. Oncology Nutrition Market High Potential Countries, Segments and Strategies

• 35.1 Oncology Nutrition Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Oncology Nutrition Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Oncology Nutrition Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer